Acorah Software Products - Accounts Production16.5.460falsetruefalsetrueNo description of principal activity15 February 202431 March 202531 March 202515491493Mrs Sarah RichardsonMr Anthony Richardsoniso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure154914932024-02-14154914932025-03-31154914932024-02-152025-03-3115491493frs-core:CurrentFinancialInstruments2025-03-3115491493frs-bus:PrivateLimitedCompanyLtd2024-02-152025-03-3115491493frs-bus:FilletedAccounts2024-02-152025-03-3115491493frs-bus:Micro-entities2024-02-152025-03-3115491493frs-bus:AuditExempt-NoAccountantsReport2024-02-152025-03-3115491493frs-bus:Director12024-02-152025-03-3115491493frs-bus:Director22024-02-152025-03-31
Registered number: 15491493
SR Pharma Research Limited
Unaudited Financial Statements
For the Period 15 February 2024 to 31 March 2025
Property Accounts Limited
SR Pharma Research Limited
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15491493
31 March 2025
£
Current assets
44,228
Creditors: Amounts Falling Due Within One Year
(10,253)
NET CURRENT ASSETS
33,975
TOTAL ASSETS LESS CURRENT LIABILITIES
33,975
NET ASSETS
33,975
CAPITAL AND RESERVES
33,975
Notes
1.General Information
SR Pharma Research Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15491493. The registered office is c/o Property Accounts Limited, 59 Castle Street, Reading, RG1 7SN.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.